2003
DOI: 10.1177/1534735403002002003
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Evaluation of “Immunoaugmentative Therapy (IAT)”: An Unconventional Cancer Treatment

Abstract: No indication of toxicity or effectiveness was found in an uncontrolled, consecutively selected series of 46 cancer patients undergoing IAT treatment. In addition, the therapy did not appear to contribute to improved quality of life in most patients. This study does not justify its continued use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
2
2

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Pfeifer and Jonas used a PODS approach to investigate Immuno-Augmentative Therapy (IAT), a CAM therapy used by thousands of cancer patients that had not been previously evaluated in a systematic fashion for either safety or efficacy. 28 This PODS demonstrated no significant improvement in cancer survival following IAT over expected outcomes when all patients were followed up. A previous best case series had reported positive outcomes for IAT.…”
Section: Evolution and Development Of Searchmentioning
confidence: 68%
“…Pfeifer and Jonas used a PODS approach to investigate Immuno-Augmentative Therapy (IAT), a CAM therapy used by thousands of cancer patients that had not been previously evaluated in a systematic fashion for either safety or efficacy. 28 This PODS demonstrated no significant improvement in cancer survival following IAT over expected outcomes when all patients were followed up. A previous best case series had reported positive outcomes for IAT.…”
Section: Evolution and Development Of Searchmentioning
confidence: 68%
“…Pfeifer and Jonas used a similar approach to investigate immuno-augmentative therapy, a CIM therapy used by thousands of cancer patients that had not been previously evaluated in a systematic fashion for either safety or efficacy. 7 The EDS was later taken over by Samueli Institute where it was further developed and renamed SEaRCH, which contained the CAP as the initial descriptive phase of CAM evaluation. 8 …”
Section: Methodsmentioning
confidence: 99%